Literature DB >> 27749291

Hydroxocobalamin for Vasoplegic Syndrome in Liver Transplantation: Restoration of Blood Pressure Without Vasospasm.

Harvey J Woehlck1, Brent T Boettcher, Kathryn K Lauer, David C Cronin, Johnny C Hong, Michael A Zimmerman, Joohyun Kim, Motaz Selim.   

Abstract

Systemic vasoplegia is common in patients undergoing liver transplantation. In this report, we present a case in which treatment with conventional vasopressors caused peripheral arterial spasm, rendering arterial blood pressure monitoring impossible. Administration of methylene blue resolved the vasospasm; however, concern for toxic dose requirements limited its use. Hydroxocobalamin administration resolved the vasospasm and increased blood pressure without the potential adverse effects seen with methylene blue. This case represents the first report of hydroxocobalamin use in liver transplantation and may represent a new option for the treatment of vasoplegia and the potential vasospasm that may result from traditional vasopressors.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27749291     DOI: 10.1213/XAA.0000000000000398

Source DB:  PubMed          Journal:  A A Case Rep        ISSN: 2325-7237


  4 in total

1.  Case report of high-dose hydroxocobalamin in the treatment of vasoplegic syndrome during liver transplantation.

Authors:  S Sandy An; C Patrick Henson; Robert E Freundlich; Matthew D McEvoy
Journal:  Am J Transplant       Date:  2018-04-02       Impact factor: 8.086

Review 2.  Vasoplegia after cardiopulmonary bypass: A narrative review of pathophysiology and emerging targeted therapies.

Authors:  Theresa J Barnes; Maxwell A Hockstein; Craig S Jabaley
Journal:  SAGE Open Med       Date:  2020-06-25

3.  The use of intravenous hydroxocobalamin as a rescue in methylene blue-resistant vasoplegic syndrome in cardiac surgery.

Authors:  Yi Cai; Anwar Mack; Beth L Ladlie; Archer Kilbourne Martin
Journal:  Ann Card Anaesth       Date:  2017 Oct-Dec

4.  High-dose hydroxocobalamin in end-stage liver disease and liver transplantation.

Authors:  Sujit Vijay Sakpal; Hannah Reedstrom; Cody Ness; Tobin Klinkhammer; Hector Saucedo-Crespo; Christopher Auvenshine; Robert N Santella; Jeffery Steers
Journal:  Drugs Ther Perspect       Date:  2019-06-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.